These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 29735617)

  • 21. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    J Urban Health; 2016 Feb; 93(1):117-30. PubMed ID: 26800987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication-assisted therapies--tackling the opioid-overdose epidemic.
    Volkow ND; Frieden TR; Hyde PS; Cha SS
    N Engl J Med; 2014 May; 370(22):2063-6. PubMed ID: 24758595
    [No Abstract]   [Full Text] [Related]  

  • 23. The Rhode Island community responds to opioid overdose deaths.
    Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
    R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Legal changes to increase access to naloxone for opioid overdose reversal in the United States.
    Davis CS; Carr D
    Drug Alcohol Depend; 2015 Dec; 157():112-20. PubMed ID: 26507172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective Use of Naloxone by Law Enforcement in Response to Multiple Opioid Overdoses.
    Kitch BB; Portela RC
    Prehosp Emerg Care; 2016; 20(2):226-9. PubMed ID: 27002349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine.
    Arendt D
    J Am Pharm Assoc (2003); 2023; 63(1):309-316. PubMed ID: 36549931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing landscape of naloxone availability in the United States, 2011 - 2017.
    Freeman PR; Hankosky ER; Lofwall MR; Talbert JC
    Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "A Blessing and a Curse:" Opioid Users' Perspectives on Naloxone and the Epidemic of Opioid Overdose.
    Kline A; Mattern D; Cooperman N; Dooley-Budsock P; Williams JM; Borys S
    Subst Use Misuse; 2020; 55(8):1280-1287. PubMed ID: 32182153
    [No Abstract]   [Full Text] [Related]  

  • 29. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Massachusetts, Vermont, and New York Are Taking Action to Address the Opioid Epidemic.
    Hernandez Y; Meyers-Ohki S; Farkas S; Ball S; Leonard K; Rotrosen J; Saitz R
    Am J Public Health; 2018 Dec; 108(12):1621-1622. PubMed ID: 30403507
    [No Abstract]   [Full Text] [Related]  

  • 31. A scoping review of post opioid-overdose interventions.
    Bagley SM; Schoenberger SF; Waye KM; Walley AY
    Prev Med; 2019 Nov; 128():105813. PubMed ID: 31437462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating Centre for Disease Control and Prevention-defined overdose risk in people prescribed opioids for chronic non-cancer pain: implications for take-home naloxone provision.
    Lintzeris N; Santo T; Nielsen S; Degenhardt L; Campbell G
    Intern Med J; 2019 Aug; 49(8):1054-1055. PubMed ID: 31387142
    [No Abstract]   [Full Text] [Related]  

  • 33. Lessons learned from the expansion of naloxone access in Massachusetts and North Carolina.
    Davis CS; Walley AY; Bridger CM
    J Law Med Ethics; 2015; 43 Suppl 1():19-22. PubMed ID: 25846157
    [No Abstract]   [Full Text] [Related]  

  • 34. Co-prescription of naloxone as a Universal Precautions model for patients on chronic opioid therapy-Observational study.
    Takeda MY; Katzman JG; Dole E; Bennett MH; Alchbli A; Duhigg D; Yonas H
    Subst Abus; 2016; 37(4):591-596. PubMed ID: 27093555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Criminal justice continuum for opioid users at risk of overdose.
    Brinkley-Rubinstein L; Zaller N; Martino S; Cloud DH; McCauley E; Heise A; Seal D
    Addict Behav; 2018 Nov; 86():104-110. PubMed ID: 29544869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OVERDOSED ON OPIOIDS: A deadly opioid epidemic sweeping the country has lawmakers working hard to find solutions.
    Hoback J
    State Legis; 2016 Apr; 42(4):9-13. PubMed ID: 27071212
    [No Abstract]   [Full Text] [Related]  

  • 38. Naloxone access among an urban population of opioid users.
    Nikolaides JK; Rizvanolli L; Rozum M; Aks SE
    Am J Emerg Med; 2018 Nov; 36(11):2126-2127. PubMed ID: 29655504
    [No Abstract]   [Full Text] [Related]  

  • 39. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "That's why we're speaking up today": exploring barriers to overdose fatality prevention in Indianapolis' Black community with semi-structured interviews.
    Seo DC; Satterfield N; Alba-Lopez L; Lee SH; Crabtree C; Cochran N
    Harm Reduct J; 2023 Oct; 20(1):159. PubMed ID: 37891632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.